These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1377 related items for PubMed ID: 26719452

  • 1. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
    Wcisło-Dziadecka D, Zbiciak-Nylec M, Brzezińska-Wcisło L, Mazurek U.
    Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
    [Abstract] [Full Text] [Related]

  • 2. Treatment of psoriasis and psoriatic arthritis.
    Papoutsaki M, Costanzo A.
    BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
    [Abstract] [Full Text] [Related]

  • 3. Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.
    Potenza MC, Peris K, Berardesca E, Bianchi L, Richetta A, Bernardini N, De Simone C, Teoli M, Zangrilli A, D'epiro S, Orsini D, Narcisi A, Chimenti S, Costanzo A.
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29215183
    [Abstract] [Full Text] [Related]

  • 4. Infliximab in psoriasis and psoriatic arthritis.
    Papoutsaki M, Osório F, Morais P, Torres T, Magina S, Chimenti S, Costanzo A.
    BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
    [Abstract] [Full Text] [Related]

  • 5. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M, Chimenti MS, Costanzo A, Talamonti M, Zangrilli A, Giunta A, Bianchi L, Chimenti S.
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [Abstract] [Full Text] [Related]

  • 6. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM, Kirby B.
    BioDrugs; 2005 Aug; 19(1):47-57. PubMed ID: 15691217
    [Abstract] [Full Text] [Related]

  • 7. Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics.
    Asahina A, Umezawa Y, Yanaba K, Nakagawa H.
    J Dermatol; 2016 Jul; 43(7):779-84. PubMed ID: 26704718
    [Abstract] [Full Text] [Related]

  • 8. PAPA Syndrome: Challenges in Achieving Long-Term Remission.
    Smajlović H, Prohić A.
    Acta Dermatovenerol Croat; 2023 Nov; 31(2):106-109. PubMed ID: 38006373
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
    Esposito M, Giunta A, Mazzotta A, Zangrilli A, Babino G, Bavetta M, Perricone R, Chimenti S, Chimenti MS.
    Dermatology; 2012 Nov; 225(4):312-9. PubMed ID: 23295383
    [Abstract] [Full Text] [Related]

  • 10. Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis.
    Bongiorno MR, Pistone G, Doukaki S, Aricò M.
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S15-20. PubMed ID: 18837728
    [Abstract] [Full Text] [Related]

  • 11. Cytokine profiles during infliximab monotherapy in psoriatic arthritis.
    Mastroianni A, Minutilli E, Mussi A, Bordignon V, Trento E, D'Agosto G, Cordiali-Fei P, Berardesca E.
    Br J Dermatol; 2005 Sep; 153(3):531-6. PubMed ID: 16120138
    [Abstract] [Full Text] [Related]

  • 12. Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.
    Saougou I, Markatseli TE, Papagoras C, Voulgari PV, Alamanos Y, Drosos AA.
    Semin Arthritis Rheum; 2011 Apr; 40(5):398-406. PubMed ID: 20843542
    [Abstract] [Full Text] [Related]

  • 13. Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.
    Torii H, Nakagawa H, Japanese Infliximab Study investigators.
    J Dermatol Sci; 2010 Jul; 59(1):40-9. PubMed ID: 20547039
    [Abstract] [Full Text] [Related]

  • 14. The quality of life in Italian psoriatic patients treated with biological drugs.
    Cozzani E, Borrini V, Pennella A, Burlando M, Cardo P, Rebora A, Parodi A.
    G Ital Dermatol Venereol; 2010 Dec; 145(6):709-12. PubMed ID: 21139547
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study.
    Aaltonen K, Heinonen A, Joensuu J, Parmanne P, Karjalainen A, Varjolahti-Lehtinen T, Uutela T, Puurtinen-Vilkki M, Arstila L, Blom M, Sokka T, Nordström D.
    Semin Arthritis Rheum; 2017 Jun; 46(6):732-739. PubMed ID: 28010883
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis.
    Mori Y, Kuwahara Y, Chiba S, Itoi E.
    Mod Rheumatol; 2015 May; 25(3):431-4. PubMed ID: 25295919
    [Abstract] [Full Text] [Related]

  • 17. Adverse reactions during biological drug therapy in psoriasis:clinical series and a review of the literature.
    Montesu MA, Addis GM, Satta R, Cottoni F.
    G Ital Dermatol Venereol; 2011 Aug; 146(4):273-81. PubMed ID: 21785393
    [Abstract] [Full Text] [Related]

  • 18. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
    Perrotta FM, Marchesoni A, Lubrano E.
    J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
    [Abstract] [Full Text] [Related]

  • 19. Clinical predictors of nonresponse to anti-TNF-α agents in psoriatic patients: A retrospective study.
    De Simone C, Caldarola G, Maiorino A, Tassone F, Campana I, Sollena P, Peris K.
    Dermatol Ther; 2016 Sep; 29(5):372-376. PubMed ID: 27146358
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A, Esposito M, Costanzo A, Chimenti S.
    Am J Clin Dermatol; 2009 Sep; 10(5):319-24. PubMed ID: 19658444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.